Table 1

Genes responsive to PI3K, mTOR and p70S6K inhibitions in breast cancer cell lines.

BT-474 breast cancer cell line, RPS6KB1-suppressed

Gene Name
Description
Inhibitor
Expression

ARL11
ADP-ribosylation factor-like 11
Ly294002
U
B2M
beta-2-microglobulin
Ly294002
U
CECR1
cat eye syndrome chromosome region, candidate 1, transcript variant 1
Ly294002
U
PCDH10
protocadherin 10, transcript variant 1
Ly294002
U
PCDH11Y
protocadherin 11 Y-linked, transcript variant c
Ly294002
U
PPP1R12B
protein phosphatase 1, regulatory (inhibitor) subunit 12B, transcript variant 3
Ly294002
U
PSORS1C1
psoriasis susceptibility 1 candidate 1
Ly294002
U
ST3GAL6
ST3 beta-galactoside alpha-2,3-sialyltransferase 6
Ly294002 rapamycin
U
CDKN2B
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4), transcript variant 1
rapamycin
U

MCF-7 breast cancer cell line, RPS6KB1-suppressed

Gene Name
Description
Inhibitor
Expression

COL5A1
collagen, type V, alpha 1
Ly294002
U
FAM5C
family with sequence similarity 5, member C
Ly294002
U
RELB
v-rel reticuloendotheliosis viral oncogene homolog B, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3 (avian)
Ly294002
U
SOX15
SRY (sex determining region Y)-box 15
Ly294002
U
ST3GAL6
ST3 beta-galactoside alpha-2,3-sialyltransferase 6
Ly294002
U
VTCN1
V-set domain containing T cell activation inhibitor 1
Ly294002
D
IFI44L
interferon-induced protein 44-like
rapamycin
D
OASL
2'-5'-oligoadenylate synthetase-like, transcript variant 1
rapamycin
D
SCD
stearoyl-CoA desaturase (delta-9-desaturase)
rapamycin
D

The genes were differentially expressed to the same direction by small molecule inhibitors and at least two RPS6KB1 siRNAs.

Abbreviations: D = downregulated expression, U = upregulated expression.

Heinonen et al. BMC Genomics 2008 9:348   doi:10.1186/1471-2164-9-348